List of Vendor Companies in Netherlands - 66

Aiosyn is a Dutch healthtech company that is developing precision pathology software solutions for breast cancer and chronic kidney disease. Aiosyn launched its first automated QC test on the EU market (AiosynQC) and the first clinical diagnostic test for breast cancer is pending regulatory approval in the EU. With our NephroPath platform we support CROs and Biopharma with quantifying kidney biomarkers thereby accelerating (pre-)clinical drug development studies.

Introduction NannoStar® and NutriSpring® are a premium quality micro-algae products for producers and end users in aquaculture and human nutrition. NannoStar and NutriSpring are 100% Dutch quality microalgae products and produced in a pristine location at the banks of the IJsselmeer at the edge of the largest protected natural area of the Netherlands. Our microalgae are grown on ancient borehole seawater (Pleistocene 130.000 years old) which is free of contamination and heavy metals. The water is extracted from 80 meters below the surface. NannoStar® and NutriSpring® are year round produced in a full controlled photobioreactor system by our dedicated team of PhD microbiologists who have 20 years of combined experience in microalgae production. The microalgae are grown on selected food grade nutrients under ISO22000 and GMP+ certification. Natural and sustainable The AlgaSpring team developed an advanced algae production system which enables the production of premium quality marine microalgae at a competitive cost level. AlgaSpring micro algae are produced environmentally friendly and no pesticides or herbicides are used. We use selected, natural algal strains and pure water and nutrient sources. Production batches are continuously monitored for quality control. AlgaSpring microalgae are cultivated in a mono-specific culture under controlled conditions in a semi-continuous process with optimum provision of nutrients, CO2, light and mixing. Cultivation and processing conditions are standardized which ensures a constant quality and a high content of valuable components in the microalgae product. AlgaSpring microalgae are produced with just daylight and no additional heating other than to keep the production facility frost free during the winter. Our marine climate zone with cool summers and mild winters ensures us of year round production at the best quality.

AMT Medical is a clinical-stage medical device company based in Ede, Netherlands, with additional facilities in Utrecht. Founded in 2015, the company specializes in developing innovative solutions for cardiac and neurosurgical bypass procedures. Their focus is on transforming bypass surgery through minimally invasive techniques, which include off-pump heart bypass surgery that avoids stopping the heart or fully opening the chest. The company offers a Cardiac Bypass System designed for keyhole and robotic surgery, which has successfully completed First-in-Human trials and is currently undergoing CE certification in Europe. Additionally, AMT Medical has commercialized a Neurosurgical Bypass Device, recognized as a Class III medical device in the EU and U.S., and noted for its life-saving capabilities. With multiple patents protecting their technology, AMT Medical aims to set a new standard in the $15 billion coronary artery disease market, targeting cardiac and neurosurgeons with their advanced solutions.

Angiocare is the only visionary and vibrant medical device partner, that distributes high quality and innovative products through knowledge and passion of our people. To a broad range of healthcare professionals and hospital administrations, who want to work with a trustworthy, do as you say-company bringing added value to a rapid changing healthcare environment with a personal touch. Angiocare is recognized as the no. 1 independent distributor in The Netherlands focusing on diagnostic and interventional therapeutic solutions in the field of Cardiology, (Neuro) Radiology, Vascular Surgery and Interventional Oncology. AngioCare is focusing primarily on cardiovascular solutions and products. We have an international network of innovative suppliers and we often bring new technologies to the Benelux countries. Our experienced sales employees are recognized as "solution bringers" in the emerging field of the mentioned markets and our logistics and order management employees have over 10 years experience in this specialized market segment. Together with our suppliers we have conducted or are conducting registries or trials with new innovative technologies to show clinical benefits for our patients.

Bespoke promoters and enhancers, for any tissue, any organism. At Annogen, our vision is a future where safe and effective advanced therapies are specifically expressed in the right tissues with no off-target effects. We believe that this can be achieved by bespoke promoters (genetic switches) and genomic expression sites. Therefore, Annogen is on a mission towards becoming the leading expertise center for gene expression engineering in order to improve the safety and effectiveness of tomorrow's cell and gene therapies. Annogen leverages its proprietary SuRE™ technology to identify regulatory DNA elements to be used for controlled (therapeutic) gene expression for gene & cell therapy, as well as for recombinant protein and virus production. In addition, we develop service projects based on our proprietary AIM™ technology to identify favorable gene insertions and their expression levels for more than 100,000 integrations in parallel. These approaches typically enable big improvements in any biomedical strategy involving the (over-) expression of genes. Annogen was founded in 2017 by Dr. Joris van Arensbergen, who developed and published the SuRE™ technology as a post-doctoral fellow in the laboratory of Prof. Dr. Bas van Steensel at the world-renowned Netherlands Cancer Institute (NKI). Today, Annogen is the trusted partner for bespoke gene expression engineering for leading biopharmaceutical, agricultural and academic research centers globally.

ANT Neuro is a Dutch corporation specialized in the development, marketing and sales of medical and research applications. ANT Neuro was established in 1997 as a spin-off company of The University of Twente, Enschede. It now has offices located in Hengelo, Netherlands; Berlin, Germany; London, UK; Philadelphia, USA; Melbourne, Australia; and Hong Kong, China. ANT Neuro specializes in being a single-source provider of high performance products within neuroscience research and neurodiagnostics. Applications include EEG, EMG, TMS and MEG technology.

Avantium develops and commercialises innovative chemistry technologies in order to produce chemicals and materials based on renewable feedstock instead of fossil resources. Our two lead products are FDCA and plantMEG™. Together, they enable the production of the novel plastic PEF: 100% plant-based, recyclable and degradable with superior performance. Avantium also provides advanced catalysis products and services to organisations who desire to gain efficiency in their processes.

Batavia Biosciences is a science-based CDMO that offers personalized services that fully support all the stages of biopharmaceutical development, from cloning to GMP manufacture and release of clinical material for phase I/II studies. We are not your standard CDMO - our customers regularly refer to us as their product development partner and thought partner. We focus on the early stages of product development with services ranging from DNA cloning, mammalian cell line generation, upstream process development, purification development, product characterization to clinical manufacturing. Headquartered in Leiden, The Netherlands, Batavia Biosciences is privileged to have strong strategic partners in both the EU and US. Batavia Biosciences aims to significantly contribute to ease human suffering from infectious disease and cancer.

Centrient Pharmaceuticals is the global business-to-business leader in sustainable, enzymatic antibiotics, next generation statins and anti-fungals. We produce and sell intermediates and active pharmaceutical ingredients (APIs), as well as our own tablets, capsules and other finished dosage forms (FDFs). We stand proudly at the centre of modern healthcare, as a maker of essential and life-saving medicines. With our commitment to Quality, Reliability and Sustainability at the heart of everything we do, our over 1,800 employees work continuously to meet our customers' needs. We work towards a sustainable future by actively participating in the fight against antimicrobial resistance. Founded 150 years ago as the ‘Nederlandsche Gist- en Spiritusfabriek', our company was known as Gist Brocades and more recently DSM Sinochem Pharmaceuticals. Headquartered in Rotterdam (Netherlands), we have production facilities and sales offices in China, India, the Netherlands, Spain, the United States and Mexico. Centrient Pharmaceuticals is owned by Bain Capital Private Equity, a leading global private investment firm.

Solvias helps innovative companies advance their path to commercialization with CMC analytical solutions powered by deep scientific expertise and a relentless focus on our customers' success. With years of expertise in small molecules, biologics and cell and gene therapies, our talented subject matter experts have the know-how, creativity, and tenacity to solve even the most complex analytical challenges. Solvias offers comprehensive solutions from raw materials to drug products to final release testing as well as API development and manufacturing for small molecules. Customers have a single, trusted analytical partner for their entire development journey. Our five global facilities are strategically placed in biopharmaceutical hubs. We are GMP, GLP and ISO certified and conduct over 100 successful customer audits every year. We take pride in putting science and quality at the heart of everything we do, helping our customers bring better and safer products to market faster.

Overview: Cibus is part of the multi-billion-dollar plant seed industry. Cibus leads the new era of high throughput gene editing technology that can develop plant traits precisely at a fraction of the time and cost of conventional breeding. Cibus is not a seed company. We are a technology company that uses gene editing to develop plant traits. Cibus licenses its traits to seed companies for royalties on seeds that use its traits. Cibus’ target market is Productivity Traits” that improve yields, lower input costs such as chemicals and increase the sustainability and profitability of farming. We have a pipeline of six productivity traits including traits for pod shatter reduction, disease resistance and nutrient use efficiency. Cibus' focus is multi-crop traits for the major crops: canola, rice, soybean, wheat, and corn. In other words, traits that can impact global agriculture sustainability at scale. Technology: Gene editing in agriculture is a plant breeding technology. The promise of gene editing in agriculture is the ability to develop plant traits that are indistinguishable from traits developed using conventional breeding but can be developed at a fraction of the time and cost. To many, gene editing represents agriculture’s “analog to digital” technology moment. It is a technology that changes the speed and scale of trait development. Cibus is at the forefront of this technology moment. Our Rapid Trait Development System™ (RTDS®) and Trait Machine™ process represents the first end-to-end semi-automated plant breeding system. Vision: Cibus’ vision is to be a pure play trait developer; a technology company whose business is to develop and license plant traits to seed companies in exchange for royalties. The licensing of plant traits and germplasm with quantifiable benefits and strong intellectual property is an integral part of the seed industry. Our goal is to be a leader in this segment of the seed industry.

CleanNA's focuses on supplying an evolving market with high quality products, providing the latest technology, high-efficiency and cost-effective magnetic bead-based kits for both DNA and RNA analysis. A dedicated team combines both scientific and technical knowledge providing an ideal interface between the user and life science application(s). Our proprietary magnetic bead technology delivers a high quality nucleic acid purification system, highly effective for cleanup of PCR and sequencing products for both Sanger Sequencing as well as Next Generation Sequencing. CleanNA offers magnetic bead-based solutions for DNA and RNA isolation from various sample sources, for example Whole Blood, FFPE, Plant tissue, etc. All our protocols are designed for high throughput nucleic acid purification and can easily be adapted on commercially available liquid handling instruments. Our proprietary chemistries can be applied in many markets including but not limited to sequencing core facilities in academic institutions, diagnostic centers, sequencing services providers around Europe and the world.

Cortalix is a clinical-stage biopharmaceutical company developing imaging diagnostics and targeted radiotherapeutics based on its proprietary single domain antibodies (nanobodies) platform. Cortalix developed a pipeline of radiopharmaceuticals that target fibrogenesis-related membrane receptors and proteins that appear in early stage fibrotic diseases such as in pulmonary fibrosis, cardiac fibrosis, hepatic fibrosis and several solid cancers with fibrotic stroma, including colon cancer and pancreatic cancer. The Cortalix technology platform is based on the screening and selection of single domain antibodies for myofibroblast-specific membrane proteins and receptors including PDGFRA (CD140a), PDGFRB (CD140b), EGFR, IGF-2R (CD222) and FAP. Our nanobodies do contain a functional group that can chelate a radionuclide suitable for nuclear imaging. Eventually the platform allows for a theranostic approach in cancer using the same single domain antibody for patient identification, targeted therapy and disease monitoring (a combined diagnostic and therapeutic in 1 molecule). Cortalix wants to share its single domain antibodies platform, the selection of new candidate molecules from it and, if appropriate, the development of new radiopharmaceuticals with others and offers this knowledge as a service, whether or not under license.

We believe Cells can theoretically produce almost anything, from fabrics to food, fuel and medicines. Designing cell-factories is hard, but our tools and machine-learning models can make it easier. Our mission is to ultimately help replace traditional farms and factories for a more sustainable world.

Cristal Therapeutics focuses on its unique and proprietary copper free click chemistry CliCr®. CliCr® has a higher stability, enables faster reactions, and generates optimal bioconjugate products. Our mission is to offer our CliCr® technology to partners under license agreements in different diagnostic and therapeutic areas.

DAB.bio develops and deploys cutting-edge fermentation technology. Our unique and patented FAST platform (Fermentation Accelerated by Separation Technology) enables continuous fermentation with cost reductions of 20-50% or more and is one of the most significant fermentation innovations of the past decade. The global focus on synthetic biology has delivered breakthrough routes to replace fossil-based chemicals with sustainable bio-based alternatives. High manufacturing costs currently hamper the large-scale manufacturing of many of these alternatives. FAST addresses this issue head-on. It is the largest contributor to lowering manufacturing costs and facilitating large-scale deployment of bio-based chemicals. DAB.bio promises a significant impact.

Digi.Bio is bridging the digital and biological world through microfluidic automation and AI. We develop programmable microfluidics platforms, integrated with sensor and AI, to make biology easier to engineer.

ENPICOM is an innovative bioinformatics software engineering company committed to accelerating biologics discovery and development through cutting-edge bioinformatics solutions. With a deep understanding of biology, software engineering, and AI, ENPICOM delivers innovative tools that empower scientists to make groundbreaking discoveries faster and more accurately. For more information visit enpicom.com.

We are Erasmus MC. Our roots lie in Rotterdam, a city and port of international standing. We are the most innovative university medical center in the Netherlands and one of the world’s leading centers of scientific research. We are committed to achieving a healthy population and pursuing excellence in healthcare through research and teaching. Day in, day out, our staff, volunteers and students work with passion and dedication to achieve everything we stand for: safe, first-rate healthcare for patients with complex issues, unusual and rare conditions or acute needs. But we also stand for top-quality teaching that attracts ambitious, inquisitive and talented students and seeks to answer the healthcare questions of tomorrow. And we stand for world-class scientific research that bolsters our understanding of diseases and disorders and helps to predict, treat and prevent them. We do our work based on our basic principles, the core values of Erasmus MC, 'responsible'​, 'connecting'​ and 'enterprising'​. We believe that we provide the best care, research and education if we are responsible, binding and enterprising.

EV Biotech is a biotechnology company that creates microbial production platforms for high-value chemicals and proteins. Our so-called microbial cell factories (MCFs) provide effective, bio-based alternatives to conventional chemical-synthetic, fossil fuel-dependent production processes. MCFs can produce sustainable, bio-based compounds for different target markets including Flavours & Fragrances, Biomaterials and Pharmaceuticals. Unique to EV’sapproach is the use of computational modelling and microorganisms. By combining classical fermentation methods with the latest developments in modelling approaches we have revolutionised the methods of microbial strain engineering.

Development, production and marketing of high end industrial two- and threephase dynamic settlers. The main international fields of application are algae harvesting, dewatering and removing (ultra)fines from Oil Based Mud. Machines are sold worldwide.

Fagron is committed to the personalization of health treatment to cover the individual patient's need through Pharmaceutical Compounding & Sterile Outsourcing Services. Pharmaceutical Compounding allows pharmacists and prescribers to create medication that satisfies patients' needs. Through our services towards personalization, we can extend the range of mass-produced medication and keep available medicaments that are no longer offered commercially in an affordable way for those who need them. Fagron was founded in the Netherlands in 1990 and is currently present in 35 countries worldwide enabling pharmacists, prescribers, hospitals, and industry to provide quality, safety, and service for their patients. Together we create the future of personalizing medicine.

New DNA technologies are rapidly being developed and will have an increasing impact on the world and on people's daily life. Future Genomics Technologies aims to translate academic knowledge and novel technologies into usable applications and provide early and easy access to these applications. Our mission is to help you achieve your goals using cutting edge sequencing and bioinformatics technology.

GC biotech, based in Waddinxveen, the Netherlands, distributes a wide range of life science products. The emphasis lies on instruments, software, kits and reagents, developed with the aim to simplify, accelerate and improve life sciences research. GC biotech combines the representation of some of the most advanced US and EU suppliers with in-house scientific and technical know-how. Since November 2012 GC biotech is ISO 9001 certified, that reflects the company's continued commitment to the highest quality standards. Over the years GC biotech has built a strong sales team with academic backgrounds in molecular biology. They are supported by an engineering team with years of experience in instrumentation and software.

GenDx is a global leader in molecular diagnostics for matching stem cell transplant patients with donors, and monitor success of transplantation. We combine our renowned software and reagents for high resolution HLA typing by Next Generation Sequencing and Chimerism monitoring, with ex-cellent customer support and education. We work closely with our partners and clients and share knowledge to advance the field of trans-plant typing and monitoring. With a highly educated and motivated team of about 90 people and 40 distributors, we contribute to the quality of life of transplant patients worldwide.

Genetwister is an innovative Dutch biotechnology company founded in 1998 specialized in molecular breeding and bioinformatics of agricultural, horticultural and ornamental plants. Through our research projects we help our customers improve crop quality to enable more sustainable farming and a more reliable food supply for the future. Our shareholders are five internationally renowned vegetable and ornamental breeding companies we are proud to serve.

Hycult Biotech is a Netherlands-based biotechnology company that specializes in research reagents and tools for complement system analysis and innate immunity research. Established in 1994, the company has over 30 years of experience in developing monoclonal antibodies, ELISA kits, and proteins aimed at advancing diagnostics and therapeutic research. Hycult serves as a trusted partner for academic, pharmaceutical, and biotech researchers, providing products to study immune-related diseases. The company emphasizes collaborative innovation, working closely with scientists worldwide to tackle challenges in disease monitoring and treatment. In 2019, Hycult enhanced its capabilities by acquiring Biocult, a specialist in monoclonal antibody production, which bolstered its contract manufacturing services. The company offers a range of products, including ELISA kits, monoclonal antibodies, and proteins, along with large-scale antibody production and support tools for data analysis.

By combining machine learning with advanced chemistry, inBiome enables microbiology labs over the world to rapidly and easily identify bacteria in a wide range of clinical sample types, including complex microbiota. Even uncultivable- and antibiotics treated species are detected. Current applications include replacing traditional culture in ICU’s for more accurate, same day results, infection control, gut flora analysis and various r&d applications for healthcare, pharmacy and food industies. Promising new applications currently undergoing clinical trials include IBD and Sepsis dagnostics and preventive screening.

Innatoss Laboratories is a Dutch research intensive organization developing and performing in vitro diagnostics of infectious diseases such as Lyme disease, Q fever and recently COVID-19. With our lab facility located in the center of the largest Q fever epidemic worldwide, we are very aware of our goal: improve diagnostics to detect these infectious diseases as early as possible and rid the world of associated health problems, such as the chronic types of these diseases. Our passion, knowledge and drive will helps us to reach our goals and to assist those who are in need of innovative diagnostics and blood testing services. Recent assignments and achievements include CE certification of the first cell-mediated immunity test for Q fever (Q-detect), consortium membership of a Q fever vaccine development program led by Massachusetts General Hospital and an EU Horizon 2020 grant for the development of a cellular Lyme diagnostic test. We are open to new opportunities, collaborations and existing developments to bring diagnostic tests for infectious diseases to the next level.

InnoCore specializes in the formulation, process development, and manufacturing of long acting and minimally invasive injectable drug delivery products. InnoCore offers a unique and highly tunable polymer platform to control the delivery drug compounds, including small molecules (e.g. peptides and low solubles) and biologics (e.g. proteins and antibodies). Our proprietary polymer platform features a variety of benefits to your API's such as: - solving toxicity challenges - maintaining/increasing stability and structural integrity of sensitive compounds (e.g. by applying low temperature process conditions during manufacturing) - sustained release of of drug molecules from days up to at least 6 months - precise control over particle size (preventing absorption by macrophages and ensuring injectability) - ensuring smooth bioavailability - enabling the use of small needle sizes for patient compliance By merging developmental collaborations and licensing partnerships with our exclusive SynBiosys biodegradable polymer technologies, we generate innovative injectable and implantable drug delivery products. We invite you to navigate through our website and discover how we can enhance the performance of your device and/or drug and add value to your product pipeline.

InnoSIGN commercializes OncoSIGNal mRNA-based tests that measure the activity of signal transduction pathways in cancer and immune cells to predict how patients will respond to targeted drugs.

Chicken hatheries normally cull male chicks at an early age since they do not produce eggs. This company has developed technology that prevents hatcheries from having to cull male chicks. They use a proprietary biomarker, high-speed sampling,and mass spectrometry to identify the gender of a chicken before the egg has hatched. Eggs with male chicks can be destroyed, thus ensuring that male chicks do not hatch and will not need to be culled.

We are Insect School. We want to create a sustainable future for our children, by unleashing a chain reaction of people and companies contributing to global circular food production. Commercially growing the Black Soldier Fly is one of the most effective steps towards this circular food production. The BSF larva provides the best source of animal protein and is a high-quality food source for pigs, chickens, fish, and pets. Our goal is to make BSF farming as commercially attractive as possible to companies. And to increase our impact, we share our knowledge and experience. With Insect School, we make our expertise available to the whole world. Insect School is founded by Insect Engineers, which develops, builds, and supplies machinery and climate systems for the global BSF industry in feed. Solutions for the entire production process, from breeding to production and processing. Find out more on www.insectengineers.com

Iribov is an international plant breeding support laboratory founded in 1992, employing around 600 people in 3 locations: in The Netherlands (Heerhugowaard), Macedonia (Vinica) and Ghana (Sogakope). The services of Iribov can be divided into 4 segments: 𝗣𝗹𝗮𝗻𝘁 𝗧𝗶𝘀𝘀𝘂𝗲 𝗖𝘂𝗹𝘁𝘂𝗿𝗲: Initiation, Virus Elimination, Naktuinbouw Elite certified production, Stock Maintainance, Protocol Development, Large Scale Propagation. 𝗕𝗿𝗲𝗲𝗱𝗶𝗻𝗴 𝗦𝘂𝗽𝗽𝗼𝗿𝘁: Gene Bank Storage in Tissue Culture, Interspecific crossing, Embryo Rescue, Mutation Induction, Dihaploid production, Polyploidization, Marker Assisted Breeding, Crispr-Cas (future development). 𝗔𝗻𝗮𝗹𝘆𝘁𝗶𝗰𝗮𝗹 𝗦𝗲𝗿𝘃𝗶𝗰𝗲𝘀: Plant pathogen detection (PCR), Seed quality control, Flowcytometry, Cytology, Biochemical Assays, Bioassays. Hardening: automated planting of tissue culture plants, vertical farm facilities, automated grading and sorting, various growing compartments and -specifications, tailor made growing solutions. The portfolio of Iribov covers over 450 plant species in 10.000 varieties for the ornamental horticulture, vegetable and (soft)fruit companies and the plantation industry worldwide.

Jeta's mission is to improve outcomes for transplant patients by providing the highest quality medical devices available. These tests will provide best in class solutions for post-transplant surveillance of disease relapse, as well as organ and stem cell transplant rejection. Jeta's systems will enable new applications, lead to improved laboratory workflows, lower per test costs and will ideally translate into better patient care and survival rates

Kyazma® focuses on genetic linkage analysis in diploid experimental populations.

LUMICKS is the leading supplier of dynamic single-molecule and cell avidity analysis instruments. Our instruments enable – for the first time – the analysis of complex dynamic details related to the behavior and interaction of single molecules and cells. Built upon innovative and Nobel Prize-winning technologies, such as optical tweezers (Nobel Prize for Physics 2018), and STED super-resolution (Nobel Prize for Chemistry 2014), our tools enable the understanding of life to the smallest detail. Our goal is to advance science and improve human health, by providing tools that unlock the measurement of forces and interactions in biology. For the first time ever, our unapparelled solutions can assist research by directly linking structural and ‘omics analysis to functional outcomes at both a molecular and a cellular level. This is achieved by applying and measuring forces around biological interactions, enabling the detailed real-time analysis of underlying biological mechanisms.

Molecular Biology Systems, B.V., founded in 2015, is a molecular biology solutions company based in the Netherlands. Our NextGenPCR thermocycler uses patented heating and cooling technology to reduce PCR amplification cycling times from hours to minutes. These technological advances support laboratories across the life sciences market, reduce costs and accelerate processing times. NextGenPCR, the amplification technology of the future, now available.

Meatable makes 100% real, delicious, guilt-free meat. With one cell, we are revolutionizing the meat industry's impact on climate change and animal welfare. At the same time we increase food security, without compromising the culinary experience of eating tasty, real meat.

MolGen is a total solutions global supplier of innovative extraction DNA / RNA technology, system, products and kits for human and animal diagnostics, agriculture and biotech.COVID-19: (-6/21) partnership with SpeeDx on COVID-19 testing.

In 2013, our Chief Scientific Officer Professor Mark Post unveiled the world’s first cultured meat hamburger to a packed press conference in London. The burger was harvested directly from cow cells, rather than raising and slaughtering a whole animal. It was the result of years of research at Maastricht University, and cost €250,000 to make. The effort was funded by Sergey Brin, the co-founder of Google. Our motivation was to find a new method to make real meat to feed our fast-growing population in a sustainable, healthy and animal-friendly way. Following the success of the first hamburger, we created Mosa Meat to commercialise cultured meat (also known as clean meat, cultivated meat or cell-based meat) and bring it to plates everywhere. In the past few years we’ve made significant scientific breakthroughs, and brought the price down considerably. We’re now focussed on scaling up the production process, and getting our first products to market.

ニコンは、100年の歴史で培ってきた「光利用技術」と「精密技術」をもとに、多彩な技術・製品・サービスをグローバルに展開しています。 映像の可能性の追求から、スマートデバイスやバイオサイエンスの進化、高度なものづくり、さらに数十億光年彼方の宇宙を捉える挑戦まで。世界中の人々の暮らしを、未来を開く最先端産業を、そして人類の挑戦を、ニコンはこれからも支え続けます。 At Nikon, we use opto-electronics and precision technologies cultivated during our 100-year history to provide a wide range of products and services globally. Our activities extend from exploring the possibilities of imaging, to advancing bioscience and smart devices, refining our high-level manufacturing processes, and capturing views of stars that are billions of light years away. Nikon will continue to enrich lives, support cutting-edge industries that are shaping the future, and confront challenges around the world.

- Our DNA - NimaGen, part of the Dutch Biolegio Holding and founded in 2011, is a well-recognized ISO certified manufacturer and vendor of reagents and workflow solutions for Sanger Sequencing and Next Generation Sequencing (NGS). We serve molecular biology laboratories around the world, active in human genetics, forensics, microbiology and infectious disease. - Our Mission - NimaGen’s mission is helping laboratories create value for their customers, through proven and cost-effective workflows, providing detailed insights and enabling informed decision making. From clinical research to forensics to agriculture to food safety and environmental hygiene. - Patented Core Technology - Our core technology, Reverse Complement PCR (RC-PCR), provides the most safe, swift and simple worklow for NGS Library Prep. It comprises simultaneous multiplex target amplification and NGS indexing or barcoding in a single, closed tube PCR assay. Compatible with illumina® and Oxford Nanopore Technologies®. - Sanger Sequencing Workflow Reagents - We are the globally recognized provider of a complete workflow portfolio of drop-in reagents for 3130, 3500, 3730 and SeqStudio™ Genetic Analyzers. From PCR purification to dyeterminator reaction cleanup and running samples, to safeguarding capillary operational life span. For DNA sequencing results and data you can trust. - Featured Brands - EasySeq™, IDseek®, BrilliantDye™, NimaPOP™, NimaPrime™, D-Pure™, iX-Pure™, ExS-Pure™, Alpaqua®, AmpliClean™, Biolegio. - Further Information - Please contact NimaGen’s resourceful specialists: • E-mail: info@nimagen.com • Website: www.nimagen.com; www.rcpcr.com • Instagram: @nimagen; LinkedIn: @NimaGen

By applying nanotechnology, photonics and machine learning, Nostics brings a new type of diagnostics to a world desperately in need for 21st century solutions. We believe that a good life starts with good health. We believe that accessible and affordable diagnostics should be a given for our entire human family. Improvements in healthcare can only start when we know what’s going on. By providing instant and affordable testing at any location, Nostics wants to contribute to a better safer and healthier world.

Ophtec is a family-owned company founded in 1983 by Prof. Dr. Jan Worst and Anneke Worst-Van Dam. Based in the Netherlands, it is a global leader in intraocular lens (IOL) innovation, specializing in solutions for cataract and refractive surgery. With a focus on pioneering ophthalmic products, Ophtec has recently modernized its brand while celebrating 40 years of excellence in the field. The company offers a range of products, including monofocal, toric, and presbyopia-correcting cataract IOLs, as well as the Artisan lens, the first iris-fixated IOL for refractive correction. Ophtec is also developing new innovations, such as the ArtiPlus lens and pre-loaded injector systems. In addition to its product offerings, Ophtec provides surgeon training and clinical support, collaborating with ophthalmologists to enhance surgical techniques and outcomes. The company is dedicated to empowering eye surgeons to deliver high-quality vision results, particularly in complex cases.

PamGene is a functional proteomics Company with a unique 3D array platform to measure the ACTIVITY of Tyrosine and Serine/Threonine kinase. We offer Products (described in our Showcase pages, PamStation-12 ®, Pamchip arrays ® and Reagent kits) and Services (lead optimization, translational/ preclinical research and biomarker discovery). We have developed powerful software tools (BioNavigator) for complex data analysis with which you can interpret results in a biological context. We support clinical trials in the oncology area. Pamgene is advancing research in Oncology as well as other areas (Neurobiology, Immunology, Metabolic disorders, cardiovascular respiratory diseases). Our technology has a wide range of Applications from fundamental and discovery research to clinical development of therapeutic and diagnostic biomarkers. Our patented technology stands out in allowing scientists in industry and academia to measure enzyme activity within a cellular context and fully decorated proteins. The assays have high sensitivity, broad kinome coverage and works for many sample sources. PamGene has a strong science foundation and the number of publications applying our technology continues to rise. PamGene's Customer Service team supports your research with dedication. The PamAcademy offers advanced training, from workflows to data analysis, interpretation and storage. PamGene's PamCloud space allows User-interaction and furthers knowledge exploration. Please visit our web site for further information (https://www.pamgene.com/) and get in touch with us! (https://www.pamgene.com/en/landing.htm)

ProteoNic is a biotechnology company active in development and licensing of DNA technology for cell line generation and recombinant protein production for pharmaceutical applications. We offer premium vector technology that substantially boosts production levels of therapeutic proteins and other biologics. Cost savings are immediate and sizeable, freeing up production capacity and enabling commercially viable production of difficult to express proteins. ProteoNic's 2G UNic™ drives higher production for all types of therapeutic protein products, including monoclonal antibodies, biosimilars and more difficult-to-express (DTE) proteins, such as Fc-fusion proteins and bi-specifics, contributing to their economic viability. Our patented technology does not require modifications to existing production systems or work flows and is compatible with all production cell lines and expression systems used in the industry. Independent technical and commercial validation by third parties, including top tier biopharma, demonstrates severalfold productivity level increases that translate into multi-million Euros in annual cost savings. The technology has wide ranging potential to boost production efficiencies in other important applications, including viral vector production, protein production in yeast and technologies which impact product quality. The company is headquartered at the BioScience Park in Leiden, the Netherlands and has a Boston, USA office for Business Development in the North American market.

Qurin Diagnostics is developing diagnostic technology platform for noninvasive testing. Current developments are focused on advanced biochip technology suitable for multiple biological and biomedical applications.

RIBOPRO is an innovative service provider, producing high-quality, high-performance RNA products, which are used as powerful research tools and therapeutics. RiboPro offers both off-the-shelf and custom RNA products at competitive rates and turn-around times, effectively removing all barriers to successful use of RNA in the research and development of our customers. We have more than 2 years experience satisfying the RNA-related needs of our (returning!) customers and thus we are confident that we can help you get your next project off to a good start. Let us worry about the quality and performance of your RNA, so you can focus on your next success.

Rijk Zwaan develops vegetable varieties and sell the seeds produced from them to growers all over the world.

Over the past decade we have transformed into a focused leader in health technology. At Philips, our purpose is to improve people’s health and well-being through meaningful innovation. We aim to improve 2.5 billion lives per year by 2030, including 400 million in underserved communities. We see healthcare as a connected whole. Helping people to live healthily and prevent disease. Giving clinicians the tools they need to make a precision diagnosis and deliver personalized treatment. Aiding the patient's recovery at home in the community. All supported by a seamless flow of data. As a technology company, we – and our brand licensees – innovate for people with one consistent belief: there’s always a way to make life better. Visit our website: http://www.philips.com/ Follow our social media house rules https://www.philips.com/a-w/about-philips/social-media.html

Met een community van duizenden medewerkers en honderdduizenden donors staat Sanquin middenin de maatschappij. Dagelijks wordt er vrijwillig en onbaatzuchtig bloed of plasma gedoneerd dat wordt verwerkt tot levensreddende bloedproducten en geneesmiddelen voor kwetsbare patiënten. Sanquin zoekt ook naar innovatieve oplossingen voor medische aandoeningen die nu nog niet (goed) te behandelen zijn. En spant zich in internationaal verband in voor de kwaliteit en optimaal gebruik van bloedproducten wereldwijd. Dit werk doen wij dagelijks met ongeveer 3000 werknemers. Onze verschillende werkgebieden zijn onderverdeeld in de volgende organisatie onderdelen: • Bloedbank • Diagnostiek • Research • Sanquinnovate • Sanquin Academy Nergens anders ter wereld komt de medische, farmaceutische en wetenschappelijke wereld zo evenwichtig bij elkaar in één innovatieve organisatie als bij Sanquin. Werken bij Sanquin doe je dan ook in een unieke werkomgeving. Kijk voor meer informatie over de verschillende werkvelden en de beschikbare vacatures op http://werkenbijsanquin.org Ben je geïnteresseerd in het donorschap, kijk voor meer informatie op http://www.sanquin.nl of doe de donortest op https://www.sanquin.nl/donortest/aanmelden Wil je samenwerken met ons, kijk dan op https://www.sanquin.org

Develops the scopeDx ® platform, a technology that uses proprietary Type III CRISPR-Cas nucleases to detect nucleic acid sequences

Develop diagnostic tools for screening of diseases through exhaled breath.

The Hyve is the data & informatics service provider for life science organizations looking to align their data infrastructure with their research needs. We provide services regarding biomedical informatics solutions to most of the top 20 biotech and pharmaceutical companies, hospitals, universities, and medical centres in the United States and Europe, including Dana Farber Cancer Institute in Boston and King’s College London. We also collaborate with biobanks, registries, and patient organisations around the world. Our mission is to enable open science by developing and implementing open-source solutions and FAIRifying data in life sciences. We have ample experience with open-source tools such as cBioPortal, Open Targets, OHDSI/OMOP, RADAR-base, and Fairspace. The Hyve can also advise on practical application and implementation of the FAIR data principles, including semantic modelling, data landscaping, and knowledge graph creation.

Thirona is a global company based in Nijmegen, the Netherlands, that specializes in AI-powered medical image analysis, focusing on lung and retina images. Founded in 2014, Thirona combines medical science with artificial intelligence to deliver advanced solutions for clinical trials, treatment development, and personalized patient care. The company offers high-precision quantitative analysis of medical images, including lung quantification software that analyzes chest CT scans for lung disease detection and treatment planning. Their services also include the quantification of anatomical volumes, mapping of parenchymal disease distributions, and analysis of airway and vascular morphology. In addition to lung analysis, Thirona provides retina image analysis solutions, such as iCare RETCAD, which detects conditions like diabetic retinopathy and glaucoma. Thirona collaborates with clinical research organizations, multinational MedTech companies, and professionals in interventional pulmonology, supporting over 600 clinical sites in more than 40 countries and contributing to over 200 scientific papers.

Uneedle realises a proprietary microneedle platform "Bella-mu" and "Bella-Vue", co-developing intradermal & suprachoroidal administered medicinal products with pharmaceutical partners. Uneedle is the legal manufacturer of this superior - short lumen - delivery platform. The single, hollow "Uneedles" are FDA approved and CE marked for direct application in the clinics worldwide.

Venus Medtech is a prominent player in transcatheter technologies for structural heart disease therapies. Our comprehensive solutions treat all four heart valves within the human heart (TAVR, TPVR, TMVR, TTVR) in addition to hypertrophic cardiomyopathy, hypertensive renal denervation therapy. Founded in 2009 and headquartered in Hangzhou National High-Tech Industrial Development Zone (Binjiang), the company successfully listed on the Main Board of the Hong Kong Stock Exchange (stock code: 2500.HK) in December 2019. Our journey began with the launch of our first product in 2014, under the New Bioprosthetic Aortic Valve Project in China. We followed this with the introduction of the VenusP-Valve in Europe in 2022. We partner with the top physicians across every continent to understand their challenges and identify opportunities. These insights drive novel breakthrough solutions for a better tomorrow. We invest more than $200M in R&D every year, operate in more than 650 centers worldwide, hold a portfolio of more than 800 patents, and boast a track record of more than 13,000 real-world implantations. As a global leader in the making, Venus Medtech's strategic focus is and will always remain to pioneer innovative technology and equip physicians with the tools they need to enhance the quality of life for patients worldwide.

VHLGenetics is a leading service provider with three business units: in The Netherlands Dr. van Haeringen Laboratorium B.V. (VHL), in Germany Certagen GmbH and in Belgium Dr. van Haeringen Polygen bvba (VHP). For more than 25 years, DNA has been the core of the organization, serving customers with routine DNA tests in non-human species. Utilizing the latest DNA technologies has enabled the VHLGenetics to grow quickly since 1993. Nowadays, our experienced laboratories offer more than 500 routine DNA tests for animals, plants and microorganisms. A few examples of routine tests in the portfolio of VHLGenetics include parentage verification, genotyping genetic traits like causal mutations, coat variation and the detection of pathogens (ParaTBC or QFever). For more information, please visit our website at www.vhlgenetics.com.

Vitestro will be the first to bring autonomous blood drawing technology to European hospitals. Blood drawing, performed billions of times per year worldwide, is key to clinical diagnosis. Given a growing population and shortages of healthcare personnel, there is a clear need for a future-proof system to keep up with demand for diagnostics.

We’re an innovative ingredients company making the potential of precision fermentation a commercial reality. We create superior dairy proteins with significantly less impact on the planet. OUR PURPOSE To make the promise of dairy protein from precision fermentation a commercial reality in order to meet the world’s growing need for nutritious, functional and sustainably-produced proteins. OUR WAY OF WORKING We create superior dairy proteins so that our customers can develop delicious products that are highly nutritious, functional and with an improved environmental footprint. We bring a deep understanding of our customers’ needs across the total value chain to our partnerships every step of the way, from our application know-how through to our supply-chain excellence. OUR FUTURE Our global food system must radically transform to meet the world's growing need for protein in a sustainable and resilient way. This requires new sources of highly nutritious and functional proteins which are significantly less demanding on our environment. With the dedication and hard work of industry experts precision fermentation will become a scalable and viable reality, leaving a better planet for future generations. WORK WITH US We want to work closely with all innovative food & beverage players who believe their brand could benefit from a more sustainably-produced & ethically-sourced yet highly functional ingredient. OUR PRODUCT Our whey protein from fermentation is available for customers now, with self-affirmed GRAS in the USA. It’s pure in beta-lactoglobulin, abundant in leucine and BCAA's, has versatile functionality, clarity in solution, and is neutral inflavor. For further information about Vivici's innovative dairy proteins from fermentation or to explore partnership opportunities, please send a message here on LinkedIn or visit us over at vivici.com.

VIVOLTA is the healthcare industry's trusted partner for contract development and manufacturing of electrospun medical products that guide the body to heal itself. Founded in 2008, we leverage our proud heritage as high-performance electrospinning equipment designer now as a leading CDMO for electrospun medical devices and drug delivery systems.

Wageningen University & Research provides education and generates knowledge in the domain of healthy food and living environment. ‘To explore the potential of nature to improve the quality of life'. That is the mission of Wageningen University & Research (WUR). A staff of 6,500 and 10,000 students from over 100 countries work everywhere around the world in the domain of healthy food and living environment for governments and the business community-at-large. The strength of WUR lies in its ability to join the forces of specialised research institutes and the University. It also lies in the combined efforts of the various fields of natural and social sciences. This union of expertise leads to scientific breakthroughs that can quickly be put into practice and be incorporated into education. This is the Wageningen Approach. The scientific quality of WUR is affirmed by the prominent position we occupy in international rankings and citation indexes.

Winclove Probiotics, quality of life with probiotics Since 1987, Winclove Probiotics has specialized in the development and production of probiotics. We work with passionate business partners, leading universities, various research institutes and university hospitals around the world to develop effective indication-specific probiotics. Aiming for long-lasting, sustainable and strategic partnerships, we not only offer innovative, high-quality and competitive probiotic solutions but also share our scientific knowledge as much as possible. At Winclove Probiotics, commitment, drive and optimism are important. Our Great Place to Work certification also shows that we have a company culture of humanity, diversity and trust. Since 2020, we have been part of the B Corp community, joining forces with like-minded companies to protect our planet and contribute to a sustainable economy. Together, we are using ‘business as a force for good'. -- Winclove Probiotics, kwaliteit van leven met probiotica Sinds 1987 is Winclove Probiotics gespecialiseerd in de ontwikkeling en productie van probiotica. Wij werken met gedreven businesspartners, vooraanstaande universiteiten, uiteenlopende onderzoeksinstituten en (universitaire) ziekenhuizen wereldwijd om effectieve indicatiespecifieke probiotica te ontwikkelen. We streven naar langdurige, duurzame en strategische partnerships waarbij wij niet uitsluitend innovatieve, hoogwaardige en concurrerende probiotica-oplossingen bieden, maar ook zoveel mogelijk onze wetenschappelijke kennis delen. Bij Winclove Probiotics zijn betrokkenheid, gedrevenheid en optimisme belangrijk. Ons Great Place to Work-certificaat toont tevens aan dat we een bedrijfscultuur van menselijkheid, diversiteit en vertrouwen hebben. Sinds 2020 zijn we onderdeel van de B Corp-community en bundelen we met gelijkgestemde bedrijven de krachten om onze planeet te beschermen en bij te dragen aan een duurzame economie. Samen gebruiken we ‘business as a force for good.'

🌱 Enjoy Handsfree Plant Production & Plant Research At WPS, we are experts in crafting, implementing, and delivering cutting-edge logistics solutions for the greenhouse horticulture industry. Our mission is to maximize your profits by providing innovative and comprehensive systems that redefine efficiency. 🤝 Customer Appreciation: Our success stems from the trust and appreciation we receive from our valued customers. We take pride in our vast knowledge, pragmatic approach, and unwavering professionalism, which drive us to exceed expectations and deliver outstanding results. 🌿 Ambitious Goals: Our ambition is clear - to continuously empower our clients with the tools they need to thrive in a competitive market. With a decisive mindset, we are committed to translating challenges into opportunities and unlocking the full potential of your greenhouse horticulture business. Join us on this journey of growth and success, and together, let's cultivate a greener future for greenhouse horticulture. #WPS #GreenhouseHorticulture #Efficiency #LogisticsSolutions #Innovation

XiltriX North America was established to make life sciences safer and more predictable through technology. We leverage 30 years of experience in safeguarding life science assets and equipment combined with robust and proven technology to revolutionize laboratory and environmental monitoring for life science industries in North America. XiltriX is the only life-sciences laboratory monitoring company capable of delivering real time alerting to prevent catastrophic equipment failures, streamlined reporting processes to comply with regulatory bodies and standards organizations, and a 24/7 monitoring team that keeps a watchful eye on operations when no one else is around. All day, every day, XiltriX acts as the pulse of your laboratory infrastructure, by protecting your science, giving you peace-of-mind and helping you sleep at night. Our system checks measurements in real-time from any number of sensors, assets, and equipment. It then logs the data securely in the cloud and generates public or personal alarms when any parameter deviates from set limits. The modular, network-based design means that it can be configured to meet any current need, with the ability to scale easily over time. XiltriX is not constrained by the physical structure of the laboratory, as data transmission can be wired, wireless or a combination of the two. The system can be fully validated and is compliant with all appropriate quality and regulatory standards: GMP, GLP, GxP, FDA 21 CFR part 11, CAP, CAPA, HACCP, JCAHO, USP 797, etc. Our subscription-based pricing includes all hardware, any necessary maintenance, repairs, and support. In addition, our Safety Net group ensures that any alerts are quickly addressed, 24/7, 365 days a year. XiltriX protects your science and helps you sleep at night.